Nu Skin Enterprises (NYSE:NUS) Issues Quarterly Earnings Results

Nu Skin Enterprises (NYSE:NUS) posted its quarterly earnings results on Thursday. The company reported $0.10 EPS for the quarter, missing analysts’ consensus estimates of $0.21 by ($0.11), FiscalAI reports. The firm had revenue of $311.01 million during the quarter, compared to analyst estimates of $328.70 million. Nu Skin Enterprises had a positive return on equity of 6.58% and a negative net margin of 15.73%.

Here are the key takeaways from Nu Skin Enterprises’ conference call:

• Nu Skin reported Q3 revenue of $311 million and adjusted EPS of $0.10, both within guidance. For the full year, it expects revenue of $1.26 billion–$1.29 billion and adjusted EPS of $0.55–$0.65.
• Profitability weakened: gross margin fell to 65% from 70.5% a year earlier, largely due to business mix, while adjusted operating margin declined to 3.7% from 5.9%. The company said customer and sales metrics in its core business remain under pressure.
• Prysm iO had approximately 41,000 devices placed and 4.5 million scans through Q3; after its app update, scan-to-purchase conversion more than doubled to 10%. LifePak sales also grew nearly 3% year to date.
• Nu Skin is investing in sales-channel training and development as it works to rebuild affiliate engagement and productivity, but management acknowledged that overall customer and sales metrics remain pressured.
• Rhyz, Nu Skin’s manufacturing platform, delivered strong year-over-year revenue growth. Management also expects its East-West operating model and regional manufacturing hubs to improve efficiency and profitability over time, though those benefits are still ahead.

Nu Skin Enterprises Stock Down 9.6%

NUS stock traded down $0.43 during midday trading on Friday, reaching $4.09. 896,360 shares of the company’s stock traded hands, compared to its average volume of 438,449. Nu Skin Enterprises has a 52 week low of $4.09 and a 52 week high of $11.67. The company has a quick ratio of 1.24, a current ratio of 1.98 and a debt-to-equity ratio of 0.36. The firm’s fifty day moving average price is $4.75 and its 200-day moving average price is $6.27. The company has a market cap of $199.34 million, a price-to-earnings ratio of -0.85 and a beta of 0.92.

Nu Skin Enterprises Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, December 9th. Shareholders of record on Friday, November 27th will be issued a dividend of $0.06 per share. The ex-dividend date of this dividend is Friday, November 27th. This represents a $0.24 annualized dividend and a yield of 5.9%. Nu Skin Enterprises’s payout ratio is presently -5.37%.

Analyst Ratings Changes

Several equities research analysts have commented on the stock. Weiss Ratings cut shares of Nu Skin Enterprises from a “sell (d+)” rating to a “sell (d)” rating in a research report on Tuesday, August 11th. Zacks Research upgraded Nu Skin Enterprises from a “strong sell” rating to a “hold” rating in a research report on Monday, October 12th. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Reduce”.

More Nu Skin Enterprises News

Here are the key news stories impacting Nu Skin Enterprises this week:

• Positive Sentiment: Nu Skin declared a quarterly dividend of $0.06 per share, payable December 9 to shareholders of record November 27. The annualized payout is $0.24 per share. Nu Skin Enterprises company information
• Neutral Sentiment: Management’s 2026 revenue guidance of $1.3 billion was in line with consensus, though it does not imply a near-term recovery in sales. Nu Skin reports third-quarter earnings
• Negative Sentiment: Third-quarter results missed estimates: revenue was $311.0 million versus $328.7 million expected, and adjusted EPS was $0.10 versus the $0.21 consensus. Revenue fell 14.6% year over year; customers, paid affiliates, and sales leaders also declined. Nu Skin Q3 earnings and revenues lag estimates
• Negative Sentiment: Nu Skin forecast 2026 EPS of $0.55–$0.65, below the $0.82 consensus estimate, signaling lower expected profitability. The company reported a GAAP loss of $0.02 per share for the quarter, compared with $0.34 EPS a year earlier. Nu Skin reports third-quarter earnings

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a global direct-selling company that develops and distributes personal care and wellness products. Its portfolio includes skincare, beauty and personal care products, nutritional supplements, and wellness-related devices and technologies. The company markets products under brands including Nu Skin and Pharmanex, with its ageLOC product line focused on skincare and age-related wellness.

Founded in 1984 and headquartered in Provo, Utah, Nu Skin sells its products primarily through a network of independent distributors, supported by digital commerce and other direct-to-consumer channels.